Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease

NCT03456232 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.

NCT NCT03456232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03456232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease
Lead sponsor
Guangdong Provincial People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 21, 2017
Completion date
March 20, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure